Mark Peakman
Mark Peakman
Professor of Clinical Immunology, King's College London
Verified email at - Homepage
Cited by
Cited by
Defective suppressor function in CD4+ CD25+ T-cells from patients with type 1 diabetes
S Lindley, CM Dayan, A Bishop, BO Roep, M Peakman, TIM Tree
Diabetes 54 (1), 92-99, 2005
Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health
S Arif, TI Tree, TP Astill, JM Tremble, AJ Bishop, CM Dayan, BO Roep, ...
The Journal of clinical investigation 113 (3), 451-463, 2004
A single autoimmune T cell receptor recognizes more than a million different peptides
L Wooldridge, J Ekeruche-Makinde, H Van Den Berg, A Skowera, ...
Journal of Biological Chemistry 287 (2), 1168-1177, 2012
CTLs are targeted to kill β cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope
A Skowera, RJ Ellis, R Varela-Calviņo, S Arif, GC Huang, C Van-Krinks, ...
The Journal of clinical investigation 118 (10), 3390-3402, 2008
Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes
TP Di Lorenzo, M Peakman, BO Roep
Clinical & Experimental Immunology 148 (1), 1-16, 2007
Antigen targets of type 1 diabetes autoimmunity
BO Roep, M Peakman
Cold Spring Harbor perspectives in medicine 2 (4), a007781, 2012
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM
MJ Hussain, M Peakman, H Gallati, SSS Lo, M Hawa, GC Viberti, ...
Diabetologia 39, 60-69, 1996
Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation
CC Chu, N Ali, P Karagiannis, P Di Meglio, A Skowera, L Napolitano, ...
Journal of Experimental Medicine 209 (5), 935-945, 2012
Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death
S Arif, F Moore, K Marks, T Bouckenooghe, CM Dayan, R Planas, ...
Diabetes 60 (8), 2112-2119, 2011
Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes
S Arif, P Leete, V Nguyen, K Marks, NM Nor, M Estorninho, ...
Diabetes 63 (11), 3835-3845, 2014
Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell–associated epitopes using combinatorial MHC multimers
JH Velthuis, WW Unger, JRF Abreu, G Duinkerken, K Franken, ...
Diabetes 59 (7), 1721-1730, 2010
Increased resistance to CD4+CD25hi regulatory T cell-mediated suppression in patients with type 1 diabetes
JM Lawson, J Tremble, C Dayan, H Beyan, RDG Leslie, M Peakman, ...
Clinical & Experimental Immunology 154 (3), 353-359, 2008
Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetes
AM Bulek, DK Cole, A Skowera, G Dolton, S Gras, F Madura, A Fuller, ...
Nature immunology 13 (3), 283-289, 2012
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment
T Orban, B Bundy, DJ Becker, LA DiMeglio, SE Gitelman, R Goland, ...
Diabetes care 37 (4), 1069-1075, 2014
Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis
TA Pollak, R McCormack, M Peakman, TR Nicholson, AS David
Psychological medicine 44 (12), 2475-2487, 2014
Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes
M Van Lummel, G Duinkerken, PA Van Veelen, A De Ru, R Cordfunke, ...
Diabetes 63 (1), 237-247, 2014
Translational mini-review series on type 1 diabetes: immune-based therapeutic approaches for type 1 diabetes
T Staeva-Vieira, M Peakman, M Von Herrath
Clinical & Experimental Immunology 148 (1), 17-31, 2007
Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers
A Lissina, K Ladell, A Skowera, M Clement, E Edwards, R Seggewiss, ...
Journal of immunological methods 340 (1), 11-24, 2009
Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
SL Thrower, L James, W Hall, KM Green, S Arif, JS Allen, C Van-Krinks, ...
Clinical & Experimental Immunology 155 (2), 156-165, 2009
A systematic review and critical evaluation of the immunology of chronic fatigue syndrome
M Lyall, M Peakman, S Wessely
Journal of psychosomatic research 55 (2), 79-90, 2003
The system can't perform the operation now. Try again later.
Articles 1–20